|
|
|
|
|
|
|
|
130th MAINE LEGISLATURE |
|
|
LD 1115 |
|
LR 1215(04) |
|
|
|
An Act To Improve
Access to HIV Prevention Medications |
|
Fiscal Note for
Bill as Engrossed with:
C "A" (S-239) |
|
Committee: Health Coverage, Insurance and
Financial Services |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fiscal Note |
|
|
|
FY 2021-22 |
FY 2022-23 |
Projections FY 2023-24 |
Projections FY 2024-25 |
Appropriations/Allocations |
|
|
|
|
|
|
Other Special Revenue Funds |
|
$43,839 |
$55,675 |
$58,640 |
$61,783 |
|
|
|
|
|
|
|
Transfers |
|
|
|
|
|
|
Other Special Revenue Funds |
|
$0 |
$0 |
$0 |
$0 |
|
|
|
|
|
|
|
Fiscal Detail and
Notes |
|
|
|
|
|
|
The bill includes
Other Special Revenue Funds allocations to the Department of Professional and
Financial Regulation of $43,839 in fiscal year 2021-22 and $55,675 in fiscal
year 2022-23 to implement the requirements of this legislation within the
Office of Professional and Occupational Licensing, Maine Board of
Pharmacy. |
|
Of this amount, the
bill includes Other Special Revenue Funds allocations to the Licensing and
Enforcement program of $41,110 in fiscal year 2021-22 and $52,328 in fiscal year 2022-23 to establish one
half-time Regulatory Health Compliance position and related All Other costs
to manage the anticipated increase in workload associated with the regulation
of pharmacists authority to dispense HIV prevention drugs. Additionally, the
bill includes Other Special Revenue Funds allocations to the Administrative
Services Division of $2,729 in fiscal year 2021-22 and $3,347 in fiscal year
2022-23 for technology-related costs associated with establishing the
Regulatory Health Compliance position.
The Office of Professional and Occupational Licensing will transfer
funds from its Licensing and Enforcement program (which includes funds for
the Maine Board of Pharmacy) to the Administrative Services Division to fund
the allocations. |
|
The Maine Board of
Pharmacy within the Office of Professional and Occupational Licensing has
sufficient resources available to support the cost of this legislation
without raising fees through the 2022-2023 biennium. However, fees may need to be increased in
future biennia if the current fee structure does not generate sufficient
revenue to cover the cost of this legislation. |
|
|
|
|
|
|
|